Literature DB >> 31207239

The Phosphatase PRL-3 Is Involved in Key Steps of Cancer Metastasis.

Laura Duciel1, Luis Cristobal Monraz Gomez2, Maria Kondratova2, Inna Kuperstein3, Simon Saule1.   

Abstract

PRL-3 belongs to the PRL phosphatase family. Its physiological role remains unclear, but many studies have identified that PRL-3 is a marker of cancer progression and shown it to be associated with metastasis. Evidence implicating PRL-3 in various elements of the metastatic process, such as the cell cycle, survival, angiogenesis, adhesion, cytoskeleton remodeling, EMT, motility and invasion, has been reported. Furthermore, several molecules acting as direct or indirect substrates have been identified. However, this information was obtained in many different studies, and it remains difficult to see the larger picture. We therefore systematically collected the published information together and used it to develop a comprehensive signaling network map. By analyzing this network map, we were able to retrieve the signaling pathways via which PRL-3 governs the key steps of the metastatic process in cancer. In this review, we summarize current knowledge of the role of PRL-3 in cancer and the molecular mechanisms involved. We also provide the web-based open-source PRL-3 signaling network map, for use in further studies.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  metastasis; phosphatase; signaling pathways; systems biology; tumorigenesis

Mesh:

Substances:

Year:  2019        PMID: 31207239     DOI: 10.1016/j.jmb.2019.06.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.

Authors:  Guennadi Kozlov; Yosuke Funato; Yu Seby Chen; Zhidian Zhang; Katalin Illes; Hiroaki Miki; Kalle Gehring
Journal:  J Biol Chem       Date:  2020-06-22       Impact factor: 5.157

2.  The Tyrosine Phosphatase PRL Regulates Attachment of Toxoplasma gondii to Host Cells and Is Essential for Virulence.

Authors:  Chunlin Yang; William J Blakely; Gustavo Arrizabalaga
Journal:  mSphere       Date:  2022-05-23       Impact factor: 5.029

3.  PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice.

Authors:  Xiao-Cui Hong; Qi-Lian Liang; Man Chen; Hai-Xia Yang; Jie Huang; Si-Lin Yi; Zhen-Wei Wang; Hai-Yan Liang; Ding-Yue Zhang; Zeng-Yi Huang
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

Review 4.  Wnt Signalling in Acute Myeloid Leukaemia.

Authors:  Alicja M Gruszka; Debora Valli; Myriam Alcalay
Journal:  Cells       Date:  2019-11-07       Impact factor: 6.600

5.  Characterizing PTP4A3/PRL-3 as the Potential Prognostic Marker Gene for Liver Hepatocellular Carcinoma.

Authors:  Xin Jin; Haida Shi; Zhi Li; Huixing Li; Huanxian Ma; Xianjie Shi
Journal:  J Oncol       Date:  2022-09-30       Impact factor: 4.501

6.  PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK.

Authors:  Qiming Zhou; Qianlei Zhou; Qinghua Liu; Zhanghai He; Yongcong Yan; Jianhong Lin; Zheng Chen; Chuanchao He; Kai Mao; Jie Wang; Zhenyu Zhou; Zhiyu Xiao; Jianlong Zhang
Journal:  Theranostics       Date:  2020-08-18       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.